Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis.

被引：0

作者：

Jani, Meghna ^{[1
]}

Chinoy, Hector ^{[1
]}

Warren, Richard B. ^{[2
]}

Griffiths, Christopher E. M. ^{[2
]}

Morgan, Ann W. ^{[3
]}

Wilson, Anthony G. ^{[4
]}

Hyrich, Kimme L. ^{[1
]}

Isaacs, John ^{[5
]}

Plant, Darren ^{[1
]}

Barton, Anne ^{[6
]}

机构：

[1] Univ Manchester, Ctr Musculoskeletal Res, Manchester 2, Lancs, England

[2] Univ Manchester, Dermatol Ctr, Manchester, Lancs, England

[3] Univ Leeds, Leeds, W Yorkshire, England

[4] Univ Coll Dublin, Dublin, Ireland

[5] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[6] Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2924

引用

页码：S1278 / S1278

页数：1

共 50 条

[21] ANTI-DRUG ANTIBODIES AS A PREDICTOR FOR THE DISCONTINUATION OF ANTI-TNF AGENTS IN PATIENTS WITH SPONDYLOARTHRTIS
Kim, H. J.
Hwang, J.
Kim, I.
Jeong, H.
Lee, J.
Jeon, C. H.
Koh, E. -M.
Cha, H. -S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 718
[22] ANTI-DRUG ANTIBODIES: ASSAY PERFORMANCE IN PATIENTS TREATED WITH ANTI-TNF BIODRUGS
Hock, B.
O'donnell, J. L.
Liu, J.
Keating, P.
Spellerberg, M.
Stamp, L.
Barclay, M.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1415 - 1415
[23] Long-term Anti-TNF therapy effects on lipoproteins concentrations in patients with active rheumatoid arthritis.
Popa, Calin
Radstake, Timothy R. D. J.
Netea, Mihai G.
Eijsbouts, Agnes E.
van den Hoogen, Frank H.
Barrera, Pilar
van der Meer, Jos W. M.
Stalenhoef, Anton F. H.
van Riel, Piet L. C. M.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S412 - S412
[24] Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease
Guerra, Ivan
Chaparro, Maria
Bermejo, Fernando
Gisbert, Javier P.
CURRENT DRUG METABOLISM, 2014, 15 (09) : 875 - 881
[25] Prediction of long-term persistency of Natalizumab anti-drug antibodies
Deisenhammer, Florian
Jank, Marlies
Lauren, Anna
Sjodin, Anders
Ryner, Mahn
Fogdell-Hahn, Anna
Sievers, Claudia
Lindberg, Raija
Jensen, Poul Erik
Christodoulou, Louis
Birchler, Mary
Auer, Michael
Pallardy, Marc
NEUROLOGY, 2017, 88
[26] FCGR2A Polymorphism and Response to Anti-TNF Treatment in Rheumatoid Arthritis.
Avila, G.
Tornero, Jesus
Fernandez Nebro, Antonio
Blanco, Francisco
Gonzalez-Alvaro, Isidoro
Canete, Juan D.
Maymo, Joan
Ballina, Javier
Fernandez Gutierrez, Benjamin
Olive, Alejandro
Corominas, Hector
Erra, Alba
Tortosa, Rauel
America Lopez-Lasanta, Maria
Aterido, Adria
Julia, Antonio
Marsal, Sara
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S496 - S496
[27] Gammaglobulins, autoantibodies, therapeutic antibodies and anti-drug antibodies in rheumatoid arthritis
Gottenberg, J. -E.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 : 115 - 117
[28] Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations
Kim, J.
Walshe, M.
Borowski, K.
Milgrom, R.
Stempak, J.
Lee, S. H.
Croitoru, K.
Silverberg, M. S.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I933 - I934
[29] Anti-Drug Antibodies As a Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis.
Hwang, Jiwon
Kim, In Young
Lee, Seulkee
Jeong, Hyemin
Kim, Hyungjin
Lee, Jaejoon
Koh, Eun-mi
Cha, Hoon-Suk
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S263 - S263
[30] SWITCHING OUT OF CLASS OR TO ANOTHER ANTI-TNF AGENT IS THE BEST STRATEGY FOR CLINICAL EFFICACY AND TREATMENT PERSISTENCE IN IBD PATIENTS WITH ANTI-DRUG ANTIBODIES AGAINST ANTI-TNF
Anjie, Suzanne I.
Hanzel, Jurij
Gecse, Krisztina B.
D'Haens, Geert
Brandse, Johannan F.
GASTROENTEROLOGY, 2023, 164 (06) : S1120 - S1121

← 1 2 3 4 5 →